期刊文献+

次氯酸对人血清白蛋白的氧化修饰影响及与高级氧化蛋白产物的关系 被引量:5

The oxidative modification of albumin by hydrochlorous acid and the relationship between the oxidized HSA and AOPPs
原文传递
导出
摘要 目的研究次氯酸对人血清白蛋白(HSA)的氧化修饰影响及与高级氧化蛋白产物(AOPPs)之间的关系。方法有氧条件下在恒定浓度的HSA(60 mg/ml)内加入不同浓度次氯酸(0、1、5、10、20、30、40、50、60 mmol/L,最终浓度),观察氧化剂对HSA的修饰作用。凝胶排阻色谱法检验HSA氧化修饰结果,在线光谱扫描(190 nm~400 nm)分析修饰产物的光谱特性。结果次氯酸可氧化修饰人血清白蛋白,其修饰产物主要为二聚体HSA和六聚体HSA。发现次氯酸对HSA单体和HSA二聚体的氧化修饰为一级反应:对诱导生成的AOPPs为准一级反应:而对诱导生成的HSA六聚体则为二级修饰反应。同时发现白蛋白对AOPPs的主要贡献者是六聚体形式的HSA,光谱分析表明HSA聚集体的最大吸收峰发生红移,提示HSA聚集体是由于蛋白中的酪氨酸残基通过氧化交联方式而聚集形成的。结论HSA经次氯酸处理后主要发生了蛋白聚集。而对AOPPs的主要贡献者是六聚体形式的HSA。 Objective To study the effect of oxidative modification of hydrochlorous acid (HOCI) on human serum albumin (HSA) and the relationship between the AOPPs and HOCl-treated liSA. Methods Purified HSA (60 mg/ml) was treated with HOCI (0, 1, 5, 10, 20, 30, 40, 50 and 60 mmol/L). Size-exclusion chromatography was applied to estimate molecular weights of oxidized products of HSA by HOCl and spectrum scan from 190 nm-400 nm was performed to observe the spectrum characteristics of all variants of HSA. Results Major products of HSA after exposure to HOCl were dimer and hexmer of HSA, The first-order process could be employed to describe the oxidative dynamics of monomer and dimer of HSA oxidized by HOCl. To AOPPs formation mediated by oxidant was identified as pseudo first-order reaction. However, formation hexmer was much in accordance with second-order reaction, Hexrner was also a major contributor to AOPPs in all types of modified HSA. Spectral analysis showed that red shift of absorbance maximum of polymers of HSA occurred, suggesting that a possibility that polymers of HSA were cross linked by tyrosine residues in protein. Conclusions Protein aggregation is primary consequence of lISA after its exposure to HOCl. Hexmer of HSA is the major contributor to AOPPs.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2006年第8期488-493,共6页 Chinese Journal of Nephrology
基金 国家自然科学基金(30300160)
关键词 白蛋白 次氯酸 氧化修饰 凝胶色谱 光谱分析 高级氧化蛋白产物 Albumin Hydrochlorous acid Oxidative modification Size-exclusion chromatography Spectral analysis Advanced oxidative protein products
  • 相关文献

参考文献17

  • 1Vanholder R, Glorieux G, Lameire N. European Uremic Toxin Work Group. Uraemic toxins and cardiovascular disease.Nephrol Dial Transplant, 2003, 18: 463-466.
  • 2Skvarilova M, Bulava A, Stejskal D, et al. Increased level of advanced oxidation protein products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.Biomed. Papers, 2005, 149: 83-87.
  • 3Stenvinkel P, Peeoits FR, Lindholm B, et al. Coronary artery disease in end-stage renal disease:no longer a simple plumbing problem. J Am Soc Nephrol, 2003,14: 1927-1939.
  • 4Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al.Advanced oxidation protein products as a new marker of oxidative stress in uremia. Kidney Int, 1996, 49: 1304-1313.
  • 5Witko-Sarsat V, Friedlander M, Nguyen-Khoa T, et al.Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure.J Immunol, 1998,161:2524-2532.
  • 6Drueke T, Witko-Sarsat V, Massy Z, et al. Iron Therapy,Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease.Circulation, 2002,106: 2212-2217.
  • 7Kaneda H, Taguchi J, Ogasawara K, et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002, 162 : 221-225.
  • 8杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量:41
  • 9K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis, 2005,45 (3 Pt 2) : 16-153.
  • 10丁峰,朱秋毓,顾勇,林善锬.高级氧化蛋白产物的主要成分分析[J].中华肾脏病杂志,2006,22(1):33-36. 被引量:11

二级参考文献34

  • 1Dhamraita SS,Stephensa JW,Coopera JA,et al.Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2.Eur Heart J Arch,2004,25:468-475.
  • 2Locatelli F,Canaud B,Eckarkt KU,et al.Oxidative stress in end-stage renal disease:an emerging threat to patient outcome.Nephrol Dial Transplant,2003,18:1272-1280.
  • 3Anraku M,Kitamura K,Shinohara A,et al.Intravenous iron administration induces oxidation of serum albumin in hemodialysis.Kidney Int,2004,66:841-848.
  • 4Witko-Sarsat V,Friedlaader M,Capeillere-Blandin C,et al.Advanced oxidation protein products as a new marker of oxidative stress in uremia.Kidney Int,1996,49:1304-1313.
  • 5Witko-Sarsat V,Friedlander M,Nguyen-Khoa T,et al.Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161:2524-2532.
  • 6Reznick AZ,Packer L.Oxidative damage to proteins:spectrophotometric method for carbonyl assay.Methods Enzymol,1994,233:357-363.
  • 7Levine RL,Garland D,Oliver CN,et al.Determination of carbonyl content in oxidatively modified proteins.Methods Enzymol,1990,186:464-468.
  • 8Davies KJA.Protein damage and degradation by oxygen radicals modification of amino acids.J Biol Chem,1987,262:9902-9907.
  • 9Heinecke JW,Li W,Francis GA,et al.Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative crosslinking of proteins.J Clin Invest,1993,91:2866-2872.
  • 10Bisby R H,Ahmed S,Cundall RB.Repair of amino acid radicals by a vitamin E analogue.Biochem Biophys Res Commun,1984,119:245-251.

共引文献48

同被引文献67

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部